Kronos International Investments

Kronos International Investments was a strategic investment and advisory firm primarily known for its foundational role in the development and financing of Phoenix Life Sciences International (formerly MediJane Holdings). Led by executive Martin Tindall, the firm specialized in providing infrastructure, capital management, and advisory services to early-stage ventures in the medical cannabis and healthcare sectors. During its peak activity in the mid-2010s, it facilitated the corporate restructuring and operational setup of cannabinoid-focused pharmaceutical projects targeting chronic pain and diabetes. The company is currently inactive, with its legacy tied to the initial professionalization and consolidation of the legal cannabis industry in the United States and Australia. It served as a key vehicle for the corporate evolution of its primary portfolio interests before their transition into independent clinical-stage entities.